Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The company is headquartered in Stockholm, Stockholm and currently employs 4,485 full-time employees. The firm offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The firm provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Follow-Up Questions
What is the price performance of EKTAF stock?
The current price of EKTAF is $5.05, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Elekta AB (publ)?
Elekta AB (publ) belongs to Health Care industry and the sector is Health Care
What is Elekta AB (publ) market cap?
Elekta AB (publ)'s current market cap is $1.8B
Is Elekta AB (publ) a buy, sell, or hold?
According to wall street analysts, 19 analysts have made analyst ratings for Elekta AB (publ), including 0 strong buy, 3 buy, 8 hold, 7 sell, and 0 strong sell
